Date:11/01/2005 URL: http://www.thehindubusinessline.com/2005/01/11/stories/2005011102360200.htm

Back Shantha Biotech unveils new vaccine delivery device

Our Bureau

Hyderabad , Jan. 10

SHANTHA Biotechnics Ltd has announced the availability of its hepatitis-B vaccine, Shanvac-B, in a unique vaccine delivery device called BD Uniject.

In a press release, the company said based on proprietary technology developed by the Programme for Advancement of Commercial Technology (PATH), supported by USAID and commercialised by Becton Dickinson (BD), Shanvac-B in BD Uniject, is another stride forward in the company's endeavour to constantly research and develop effective biotechnology products for human care and patient safety.

The company said Shanvac-B in BD Uniject was unveiled at the PEDICON-2005 symposium, held in Kolkata on Saturday.

Shanvac-B in BD Uniject is a single-dose, single-use injection device that guarantees the integrity and sterility of Shanvac-B right up to the final moment of use, the company said. The BD Uniject device prevents any scope of tampering or contamination from the outside environment. The absence of glass, rubber or silicone ensures that there is no chance of particulate matter mixing with the vaccine, the company said.